We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$6.08M
BI
2
BVF Inc
California
$4.53M -$3.27M -59,700 -41%
OFM
3
Omega Fund Management
Massachusetts
$4M
IVM
4
InterWest Venture Management
California
$3.6M
FM
5
Frazier Management
Washington
$3.48M
AC
6
Aisling Capital
New York
$2.71M
OM
7
Opaleye Management
Massachusetts
$2.65M -$548K -10,000 -17%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.56M +$276K +5,030 +12%
ACM
9
Alethea Capital Management
Washington
$1.5M +$225K +4,098 +17%
MIM
10
Monashee Investment Management
Massachusetts
$1.27M
GIM
11
Granahan Investment Management
Massachusetts
$1.17M -$84.1K -1,534 -7%
Renaissance Technologies
12
Renaissance Technologies
New York
$1.05M +$220K +4,012 +25%
RJA
13
Raymond James & Associates
Florida
$794K -$86.9K -1,585 -10%
FI
14
Fosun International
China
$773K
BlackRock
15
BlackRock
New York
$739K -$35.7K -651 -4%
Millennium Management
16
Millennium Management
New York
$603K +$45.8K +835 +8%
PM
17
Prosight Management
Texas
$584K -$69.9K -1,275 -10%
DCM
18
DAFNA Capital Management
California
$564K
WFI
19
West Family Investments
California
$561K +$32.6K +594 +6%
TCM
20
Tekla Capital Management
Massachusetts
$421K
RJFSA
21
Raymond James Financial Services Advisors
Florida
$385K -$342K -6,233 -46%
OAM
22
Oxford Asset Management
United Kingdom
$257K -$72.7K -1,326 -21%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$254K -$70.5K -1,285 -21%
BCM
24
Bridgeway Capital Management
Texas
$250K +$82.2K +1,500 +47%
TMC
25
Trellus Management Company
Florida
$249K